ID   ICBD-1
AC   CVCL_L093
DR   Wikidata; Q54897222
RX   CelloPub=CLPUB00275;
RX   PubMed=9468580;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: ~31.5 hours (Note=At 30th passage) (PubMed=9468580).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
RX   CelloPub=CLPUB00275;
RA   Zach S., Birgin E., Ruckert F.;
RT   "Primary cholangiocellular carcinoma cell lines.";
RL   J. Stem Cell Res. Transplant. 2:1013-1013(2015).
//
RX   PubMed=9468580; DOI=10.3892/or.5.2.463;
RA   Takiyama I., Terashima M., Ikeda K., Kawamura H., Kashiwaba M.,
RA   Tamura G., Suto T., Nakashima F., Sasaki R., Saito K.;
RT   "Establishment and characterization of a new human extrahepatic bile
RT   duct carcinoma cell line (ICBD-1).";
RL   Oncol. Rep. 5:463-467(1998).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//